LAMP5 may promote MM progression by activating p38

Area of Science:

• Hematologic Oncology
• Molecular Biology
• Biochemistry

Background:

• Multiple myeloma (MM) is the second most common hematologic malignancy and remains incurable.
• Identifying key genes in MM pathogenesis is crucial for developing new therapeutic strategies.

Purpose of the Study:

• To identify key genes involved in the pathogenesis and progression of multiple myeloma using bioinformatics analysis.
• To investigate the role of Lysosome associated membrane protein 5 (LAMP5) in MM development and its potential as a therapeutic target.

Main Methods:

• Bioinformatics analysis to identify candidate genes.
• Quantitative PCR (qPCR) and Western blotting to validate LAMP5 expression in patient samples and cell lines.
• LAMP5 gene silencing in MM cell lines (RPMI-8226, AMO-1).
• Flow cytometry and Western blotting to assess apoptosis and cell cycle.
• Mechanistic investigation involving p38 protein activation.

Main Results:

• LAMP5 expression progressively increased from healthy donors (HD) to monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), newly diagnosed MM (NDMM), and relapsed MM (RMM).
• High LAMP5 expression in NDMM patients correlated with higher Durie-Salmon (DS) stage and worse prognosis.
• Silencing LAMP5 in MM cell lines promoted apoptosis but did not affect the cell cycle.
• LAMP5 may promote MM progression through activation of the p38 protein pathway.

Conclusions:

• LAMP5 is identified as a key gene in multiple myeloma progression and recurrence.
• LAMP5 promotes MM cell survival and progression, potentially through p38 protein activation.
• LAMP5 represents a potential therapeutic target for multiple myeloma.